MVA-BN Brachyury Publications
Publications on or relating to MVA-BN Brachyury.
Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responsesJ Immunother Cancer 2015, 3(Suppl 2):P132
Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer.Clin Cancer Res. 2012;18:3868-3879.
The basics of epithelial-mesenchymal transition.J Clin Invest. 2009;119:1420-1428.